The role of EIF4G2 in CRC is not well studied, although it is reported to control the G1 phase inhibitor p27Kip1 to alter proliferation in glioblastoma, human embryonic kidney and AML cells [46,55]. This evidence concerns the gene EIF4G2 and colorectal carcinoma.